The Business Research Company published its Conjugated Monoclonal Antibodies Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Conjugated Monoclonal Antibodies market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers
the Conjugated Monoclonal Antibodies market’s segments-
1) By Drugs:
Adcetris, Kadcyla
2) By Technology:
Cleavable Linker, Non-cleavable Linker
3) By
Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain
Tumor, Others.
View Complete Report:
Conjugated Monoclonal Antibodies Global
Market Report 2020 is the most comprehensive report available on this market and will help gain a truly
global perspective as it covers 60 geographies. The chapter on the impact of
COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
The global conjugated monoclonal antibodies
market is expected to decline from $8.35 billion in 2019 to $8.15 billion in
2020 at a compound annual growth rate (CAGR) of -2.36%. The decline is mainly
due to the COVID-19 outbreak that has led to restrictive containment measures
involving social distancing, remote working, and the closure of industries and
other commercial activities resulting in operational challenges. The entire
supply chain has been disrupted, impacting the market negatively. The market is
then expected to recover and reach $10.41 billion in 2023 at a CAGR of 8.49%.
Companies operating in the conjugated
monoclonal antibodies market are focusing on strategic collaborations and
partnerships.
Few Points From The Table Of Contents
1. Executive
Summary
2. Conjugated
Monoclonal Antibodies Market Characteristics
3. Conjugated Monoclonal
Antibodies Market Size And Growth
4. Conjugated
Monoclonal Antibodies Market Segmentation
5. Conjugated
Monoclonal Antibodies Market Regional And Country Analysis
….
26. Key Mergers And
Acquisitions In The Conjugated Monoclonal Antibodies Market
27. Conjugated
Monoclonal Antibodies Market Trends And Strategies
28. Conjugated
Monoclonal Antibodies Market Future Outlook and Potential Analysis
29. Appendix
Request For A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3424&type=smp
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $
Billion
Table 2: Global
Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global
Conjugated Monoclonal Antibodies Market, Segmentation By Drugs, Historic and
Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global
Conjugated Monoclonal Antibodies Market, Segmentation By Technology, Historic
and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 5: Global
Conjugated Monoclonal Antibodies Market, Segmentation By Application, Historic
and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
……..
Table 46: Pfizer Inc. Financial Performance
Table 47: F.
Hoffmann-LA Financial Performance
Table 48: Bristol
-Myers Squibb Financial Performance
Table 49: Merck
& Co. Inc. Financial Performance
Table 50:
Immunomedics Inc. Financial Performance
About The Business Research Company:
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment